PRKAR2B promotes prostate cancer metastasis by activating Wnt/β‐catenin and inducing epithelial‐mesenchymal transition
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.27030
Abstract: Castration‐resistant prostate cancers (CRPC) that occur after the failure of androgen‐blocking therapies cause most of the deaths in prostate cancer (PCa) patients. In a previous study we identified that PRKAR2B expression is upregulated in CRPC… read more here.
Keywords: prostate cancer; metastasis; prkar2b; cancer ... See more keywords